首页> 外文期刊>RSC Advances >Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: key intermediate of ticagrelor
【24h】

Highly enantioselective bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one: key intermediate of ticagrelor

机译:1-(3,4-二氟苯基)-3-硝基丙烷-1-1的高度映射性生物诱导:TicagreloLor的关键中间体

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, highly effective and economical whole-cell mediated process was developed for the biocatalytic reduction of a ketone, intermediate in the synthesis of platelet inhibiting drug ticagrelor. Sixteen different microorganisms were screened for the bioreduction of 1-(3,4-difluorophenyl)-3-nitropropan-1-one (1) to (S)-1-(3,4-difluorophenyl)-3-nitropropan-1-ol (2). Growing as well as resting cells of Candida parapsilosis 104659 exhibited high conversion (>99.0%) and enantioselectivity (98.0%) for the S-enantiomer.
机译:一种简单,高效且经济的全细胞介导的过程是为生物催化的酮,中间体在血小板抑制药物TiCagreles的合成中进行了一种简单,高效和经济的全细胞介导的方法。 将十六种不同的微生物筛选为1-(3,4-二氟苯基)-3-硝基丙烷-1-一(1)至(S)-1-(3,4-二氟苯基)-3-硝基丙烷-1-的生物诱导 ol(2)。 生长以及念珠菌穴位104659的静息细胞表现出高转化(> 99.0%)和S-映体的映射性(98.0%)。

著录项

  • 来源
    《RSC Advances》 |2016年第41期|共5页
  • 作者单位

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

    Chirotech Technol Ltd 410 Cambridge Sci Pk Milton Rd Cambridge CB4 OPE Cambs England;

    Dr Reddys Labs Ltd Integrated Prod Dev Innovat Plaza Qutubullapur 500072 Andhra Pradesh India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号